Correlation Between Evoke Pharma and Serina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evoke Pharma and Serina Therapeutics, you can compare the effects of market volatilities on Evoke Pharma and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Serina Therapeutics.

Diversification Opportunities for Evoke Pharma and Serina Therapeutics

0.59

Correlation Coefficient

Evoke Pharma  Serina Therapeutics

Very weak diversification

The 3 months correlation between Evoke and Serina is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Serina Therapeutics go up and down completely randomly.

Pair Corralation between Evoke Pharma and Serina Therapeutics

Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.86 times more return on investment than Serina Therapeutics. However, Evoke Pharma is 1.16 times less risky than Serina Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Serina Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  517.00  in Evoke Pharma on October 9, 2024 and sell it today you would lose (57.00) from holding Evoke Pharma or give up 11.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Evoke Pharma  vs.  Serina Therapeutics

Evoke Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Evoke Pharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Serina Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Evoke Pharma and Serina Therapeutics

The main advantage of trading using opposite Evoke Pharma and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.

The idea behind Evoke Pharma and Serina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.